Dr Paul Gavin

Avecho CEO confident ahead of CBD insomnia trial's pivotal interim results

Medical

Avecho CEO confident ahead of CBD insomnia trial's pivotal interim results

March 26, 2026

Company Roundup: Avecho, InhaleRx, Neurotech, Peak, Zelira, Argent

Finance

Company Roundup: Avecho, InhaleRx, Neurotech, Peak, Zelira, Argent

February 02, 2026

Avecho Secures US and European Patent Allowances; Montu Grows Medical Affairs Division

General

Avecho Secures US and European Patent Allowances; Montu Grows Medical Affairs Division

December 09, 2025

FY25 pay packets: what Australia's listed cannabis executives took home

Finance

FY25 pay packets: what Australia's listed cannabis executives took home

October 22, 2025

Shahin Takes Top Stake in Vitura; Avecho, Epsilon and Zelira Post Key Updates

Medical

Shahin Takes Top Stake in Vitura; Avecho, Epsilon and Zelira Post Key Updates

July 31, 2025

Sandoz Partnership Propels Avecho's CBD Insomnia Trial Expansion Across Australia

Medical

Sandoz Partnership Propels Avecho's CBD Insomnia Trial Expansion Across Australia

May 20, 2025

Avecho CEO predicts takeover, soaring valuation if CBD sleep capsule clears phase III trial

Medical

Avecho CEO predicts takeover, soaring valuation if CBD sleep capsule clears phase III trial

March 11, 2025

Sandoz commits A$4.8 million to Avecho in push for over-the-counter CBD sleep treatment

Finance

Sandoz commits A$4.8 million to Avecho in push for over-the-counter CBD sleep treatment

March 03, 2025

Avecho Enrolls First Patient in Pivotal Phase III CBD Insomnia Study

Medical

Avecho Enrolls First Patient in Pivotal Phase III CBD Insomnia Study

May 16, 2024

Avecho Opens Enrolment for Large-Scale CBD Insomnia Study

Medical

Avecho Opens Enrolment for Large-Scale CBD Insomnia Study

March 26, 2024

Avecho Wins Ethics Approval to Launch Phase III Insomnia CBD Trial

Medical

Avecho Wins Ethics Approval to Launch Phase III Insomnia CBD Trial

March 07, 2024

Avecho Biotechnology Secures Additional A$6m, Bringing Total Raise to $8m Ahead of Clinical Trial

Finance

Avecho Biotechnology Secures Additional A$6m, Bringing Total Raise to $8m Ahead of Clinical Trial

August 28, 2023

Avecho Biotechnology Finalises TPM-Enhanced CBD Gummy After Development Push

Medical

Avecho Biotechnology Finalises TPM-Enhanced CBD Gummy After Development Push

June 14, 2023

Industry Roundup: Asterion Cleared; Ecofibre Patents; Avecho Trial Prep; Epsilon, Creso Pharma, Cann Global Updates

Finance

Industry Roundup: Asterion Cleared; Ecofibre Patents; Avecho Trial Prep; Epsilon, Creso Pharma, Cann Global Updates

May 18, 2023

Avecho Seeks Fresh Investment to Bridge Gap in CBD Trial Funding Drive

Finance

Avecho Seeks Fresh Investment to Bridge Gap in CBD Trial Funding Drive

May 09, 2023

Finance

Avecho Launches A$11m Share Raise to Fund CBD Insomnia Trial

April 03, 2023

Lambert Initiative to Investigate Avecho CBD Capsules Across Two New Clinical Trials

Medical

Lambert Initiative to Investigate Avecho CBD Capsules Across Two New Clinical Trials

February 22, 2023

Industry Updates: Avecho, Levin Health, Cannatrek, Releaf Group, Bod Science

Legal

Industry Updates: Avecho, Levin Health, Cannatrek, Releaf Group, Bod Science

December 22, 2022

Avecho's TPM CBD Formula Outperforms Epidyolex on Absorption in Dog Study

Medical

Avecho's TPM CBD Formula Outperforms Epidyolex on Absorption in Dog Study

September 19, 2022

Updates from Eight Cannabis-Focused Companies: Financial Results and Clinical Progress

Finance

Updates from Eight Cannabis-Focused Companies: Financial Results and Clinical Progress

March 03, 2022

Medical

Avecho begins observational study to test oral CBD formulation on human patients

January 04, 2021